Tocqueville Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-374
Closed -$616K 755
2019
Q2
$616K Sell
374
-347
-48% -$600K 0.01% 555
2019
Q1
$1.47M Buy
721
+374
+108% +$659K 0.02% 419
2018
Q4
$446K Sell
347
-3,880
-92% -$5.95M 0.01% 576
2018
Q3
$8M Buy
4,227
+109
+3% +$225K 0.1% 220
2018
Q2
$8.37M Buy
4,118
+2,114
+105% +$4.82M 0.11% 206
2018
Q1
$4.43M Sell
2,004
-224
-10% -$570K 0.06% 321
2017
Q4
$5.14M Sell
2,228
-2,071
-48% -$4.2M 0.06% 307
2017
Q3
$7.65M Buy
4,299
+1,883
+78% +$2.63M 0.09% 244
2017
Q2
$3.29M Hold
2,416
0.04% 357
2017
Q1
$2.84M Sell
2,416
-887
-27% -$905K 0.03% 377
2016
Q4
$2.64M Buy
3,303
+428
+15% +$340K 0.03% 373
2016
Q3
$2.52M Sell
2,875
-1,201
-29% -$870K 0.03% 378
2016
Q2
$2.29M Sell
4,076
-68
-2% -$38.5K 0.03% 395
2016
Q1
$2.28M Buy
4,144
+486
+13% +$298K 0.03% 384
2015
Q4
$3.04M Buy
3,658
+387
+12% +$387K 0.04% 359
2015
Q3
$3.62M Buy
3,271
+867
+36% +$1.58M 0.05% 342
2015
Q2
$5.24M Buy
2,404
+562
+31% +$1.14M 0.06% 305
2015
Q1
$2.88M Buy
1,842
+607
+49% +$801K 0.03% 411
2014
Q4
$1.47M Buy
1,235
+270
+28% +$180K 0.02% 518
2014
Q3
$449K Buy
965
+347
+56% +$160K 0.01% 645
2014
Q2
$309K Sell
618
-278
-31% -$89.1K ﹤0.01% 856
2014
Q1
$264K Buy
896
+772
+623% +$234K ﹤0.01% 730
2013
Q4
$34K Buy
+124
New +$34.6K ﹤0.01% 1095

Other funds holding BLUE

Tocqueville Asset Management's BLUE Position: Q3 2019 in Review

Tocqueville Asset Management sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 374 shares — an estimated $616K sold.

Tocqueville Asset Management first reported a position in BLUE in Q4 2013 and held it in 23 quarters. The position peaked at $8.37M in Q2 2018. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • Tocqueville Asset Management reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • Tocqueville Asset Management sold 374 bluebird bio shares in Q3 2019, an estimated $616K.
  • Tocqueville Asset Management first reported a position in bluebird bio in Q4 2013 and held it in 23 quarters.
  • Tocqueville Asset Management's bluebird bio position peaked at $8.37M in Q2 2018.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Tocqueville Asset Management's 13F filing for Q3 2019, filed 31 Oct 2019.